Alkermes, Inc.
NASDAQ: ALKS
$29.79
-$0.90 (-2.9%)
Closing price September 16, 2021
Thursday’s top analyst upgrades and downgrades included Advanced Micro Devices, Alkermes, Clover Health, Okta, Peloton Interactive, Starbucks and Unilever.
14 days ago
Last Updated: 8 days ago
Thursday's top analyst upgrades and downgrades included Alkermes, Amazon.com, Citigroup, eBay, Fastly, Groupon, Lyft, Netflix, ONEOK, Roku, Uber Technologies and Zoom Video Communications.
11 months ago
Last Updated: 10 months ago
Friday's top analyst upgrades, downgrades and initiations included Alkermes, Aurora Cannabis, BlackRock, Duke Energy, Nvidia, Ralph Lauren, SunPower, Veeva Systems and Yelp.
1 year ago
Last Updated: 1 year ago
Biogen and Alkermes have announced that the FDA approved Vumerity for the treatment of relapsing forms of multiple sclerosis.
1 year ago
Last Updated: 1 year ago
Alkermes shares made a handy gain on Monday after the firm announced that it would be expanding its New Drug Application for ALKS 3831 to encompass the treatment of bipolar I disorder in addition to...
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and initiations on Monday included Agilent Technologies, Amazon.com, American Water Works, Crocs, Deere, General Electric, Gilead Sciences, Slack and Teva...
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and initiations seen on Friday included Alkermes, Apple, Canada Goose, FireEye, J.Jill, Kraft Heinz, Uber Technologies and Vonage.
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and initiations seen on Wednesday included Alkermes, Alphabet, Apple, ConocoPhillips, FireEye, Lyft, McDonald's, Royal Bank of Scotland, Seagate Technology and...
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Baker Hughes, Biogen, FedEx, Intel, Micron Technology, Roku and Shake Shack.
2 years ago
Last Updated: 1 year ago
Alkermes shares dropped early on Friday after the company anncounced the results from its most recent meeting with the U.S. Food and Drug Administration.
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and other research calls from Tuesday include Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts and Zillow.
3 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and other research calls from Wednesday include Alkermes, Cigna, International Paper, Medtronic, Tesla and Western Digital.
3 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and other research calls from Friday included AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp and Sarepta Therapeutics.
3 years ago
Last Updated: 1 year ago
Shares of Alkermes saw a handy gain to start out the week after the FDA made a critical decision about its treatment for major depressive disorder.
3 years ago
Last Updated: 1 year ago
Alkermes saw its shares drop early on Monday after the company announced that it received a Refusal to File letter from the FDA.
3 years ago
Last Updated: 1 year ago